Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Stacey Lacoste"'
Autor:
Jennifer N. Abi Younes, John R. Campbell, Simon J. G. Otto, Sheryl P. Gow, Amelia R. Woolums, Murray Jelinski, Stacey Lacoste, Cheryl L. Waldner
Publikováno v:
Antibiotics, Vol 13, Iss 4, p 322 (2024)
Antimicrobials are crucial for treating bovine respiratory disease (BRD) in beef feedlots. Evidence is needed to support antimicrobial use (AMU) decisions, particularly in the early part of the feeding period when BRD risk is highest. The study objec
Externí odkaz:
https://doaj.org/article/bf65ba926e294d209923303c50d65b3f
Autor:
Nathan E N, Erickson, Adam, Berenik, Herbert, Lardner, Stacey, Lacoste, John, Campbell, Sheryl, Gow, Cheryl, Waldner, John, Ellis
Publikováno v:
Can Vet J
Bovine respiratory disease (BRD) is an economically important cause of morbidity and mortality in beef calves. Control of BRD is most often addressed through “homologous” vaccination utilizing the same injectable modified-live viral (MLV) vaccine
Autor:
Elena Marzo, Marta Sitja, Ricard March, Stacey Lacoste, Mercè Roca, John A. Ellis, Carlos Montbrau, Sheryl Gow, Maria-Carmen Moreno
Publikováno v:
The Veterinary recordREFERENCES. 188(11)
Background Bovine respiratory syncytial virus (BRSV) is a major problem for cattle worldwide during their first year of life. The aim of the present study was to evaluate efficacy and longevity of immunity of a live vaccine (NASYM, HIPRA) in the pres
Publikováno v:
Can J Vet Res
Bovine respiratory disease complex is etiologically complex and usually involves co-infection by several agents, including bovine parainfluenza virus-3 (BPIV-3), bovine respiratory syncytial virus (BRSV), and bovine coronavirus (BCoV). Traditionally,
Publikováno v:
The Canadian veterinary journal = La revue veterinaire canadienne. 59(12)
Bovine respiratory syncytial virus (BRSV) is the leading cause of viral pneumonia in calves, making young passively immune calves candidates for vaccination, and raising issues concerning boosting of neonatally primed responses. To address this, 18,
Autor:
Z. Xu, Cheryl L. Waldner, S. Shields, John A. Ellis, E. Ball, Sheryl Gow, A. Bowers, S. Wappel, Stacey Lacoste
Publikováno v:
The Veterinary Journal. 212:71-77
In order to determine the comparative efficacy of vaccines administered intranasally or orally to protect puppies from disease subsequent to experimental infection with Bordetella bronchiseptica (Bb), a randomized controlled trial was performed using
Publikováno v:
The Canadian veterinary journal = La revue veterinaire canadienne. 59(5)
In order to determine whether nasal secretions of young calves contain passively derived antibodies to bovine respiratory syncytial virus (BRSV) and if there are differences in presence and/or subclass of these antibodies between calves fed different
Publikováno v:
Gray, D, Ellis, J A, Gow, S P, Lacoste, S R, Allan, G M & Mooney, M H 2019, ' Profiling of local disease-sparing responses to bovine respiratory syncytial virus in intranasally vaccinated and challenged calves ', Journal of proteomics, vol. 204, 103397 . https://doi.org/10.1016/j.jprot.2019.103397
Bovine and human respiratory syncytial viruses (BRSV, HRSV) are primary causes of pneumonia in calves and children respectively, with vaccination offering protection via antibody and cellular immune responses. However, with no vaccines currently lice
Autor:
John, Ellis, Sheryl, Gow, Carrie, Rhodes, Stacey, Lacoste, Lyndsay, Kong, Kristyna, Musil, Elisabeth, Snead
Publikováno v:
The Canadian veterinary journal = La revue veterinaire canadienne. 57(5)
The immune responses in control dogs [1 to 4 years of age, body condition score (BCS): 4 to 5 out of 9] were compared to those of aging dogs (based on breed and body size) either categorized as lean (BCS: 4 to 5 out of 9) or obese (BCS: 8 to 9 out of
Autor:
Klaus S. Gutfreund, Stacey Lacoste, William R. Addison, Sheryl L. Gares, Karl P. Fischer, Stephen E. Congly, D. Lorne Tyrrell
Engagement of CD154 on activated T cells with CD40 on antigen-presenting cells (APCs) potentiates adaptive immune responses in mammals. Soluble multimeric forms of CD154 have been used as an adjuvant or in immunotargeting strategies to enhance vaccin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b57357f1e94efec1bdc33868e063707
https://europepmc.org/articles/PMC1539120/
https://europepmc.org/articles/PMC1539120/